IVVD · Insider Trading
Invivyd, Inc. Common Stock
Every open-market purchase and sale reported by IVVD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Ian Sheffield | Director | A | +100,000 deriv. | — |
| 2026-09-01 | Marc Elia | Chief Executive Officer | A | +10,700,000 deriv. | — |
| 2026-08-18 | William E. Duke | Chief Financial Officer | MIXED | +61,220 | −$31.67K |
| 2026-08-18 | Timothy Edward Lee | Chief Commercial Officer | MIXED | +61,220 | −$31.67K |
| 2026-08-18 | Julie Green | Chief Human Resources Officer | MIXED | +61,220 | −$31.67K |
| 2026-08-18 | Jill Andersen | Chief Legal Officer, Secretary | MIXED | +102,038 | −$52.78K |
| 2026-08-18 | Robert D. Allen III | Chief Scientific Officer | MIXED | +64,278 | −$29.30K |
| 2026-08-04 | Michael Mina | CMO and Chief Epidemiologist | A | +1,125,000 deriv. | — |
| 2026-05-21 | Terrance McGuire | Director | A | +50,000 deriv. | — |
| 2026-05-21 | Paul Bolno | Director | A | +32,876 deriv. | — |
| 2026-05-21 | Ajay Royan | Director | A | +50,000 deriv. | — |
| 2026-05-21 | Kevin F McLaughlin | Director | A | +50,000 deriv. | — |
| 2026-05-21 | M28 Capital Management LP | — | A | +50,000 deriv. | — |
| 2026-05-21 | Tamsin Berry | Director | A | +50,000 deriv. | — |
| 2026-02-18 | Jill Andersen | Chief Legal Officer, Secretary | MIXED | +97,290 | −$105.58K |
| 2026-02-18 | Julie Green | Chief Human Resources Officer | MIXED | +58,373 | −$63.35K |
| 2026-02-18 | Robert D. Allen III | Chief Scientific Officer | MIXED | +61,419 | −$58.60K |
| 2026-02-18 | Timothy Edward Lee | Chief Commercial Officer | MIXED | +58,373 | −$63.35K |
| 2026-02-18 | William E. Duke | Chief Financial Officer | MIXED | +58,373 | −$63.35K |
| 2026-01-30 | William E. Duke | Chief Financial Officer | A | +625,000 deriv. | — |
| 2026-01-30 | Robert D. Allen III | Chief Scientific Officer | A | +625,000 deriv. | — |
| 2026-01-30 | Jill Andersen | Chief Legal Officer, Secretary | A | +820,000 deriv. | — |
| 2026-01-30 | Julie Green | Chief Human Resources Officer | A | +675,000 deriv. | — |
| 2026-01-30 | Timothy Edward Lee | Chief Commercial Officer | A | +675,000 deriv. | — |
| 2025-11-20 | Kevin F McLaughlin | Director | Buy | +50,000 | +$125.00K |
| 2025-09-24 | Paul Bolno | Director | A | +100,000 deriv. | — |
| 2025-08-19 | Jill Andersen | Chief Legal Officer, Secretary | MIXED | +82,246 | −$49.68K |
| 2025-08-19 | Julie Green | Chief Human Resources Officer | MIXED | +49,344 | −$29.81K |
| 2025-08-19 | William E. Duke | Chief Financial Officer | MIXED | +49,344 | −$29.81K |
| 2025-08-19 | Timothy Edward Lee | Chief Commercial Officer | MIXED | +49,344 | −$29.81K |
| 2025-08-19 | Robert D. Allen III | Chief Scientific Officer | MIXED | +53,068 | −$27.57K |
| 2025-05-22 | Kevin F McLaughlin | Director | A | +50,000 deriv. | — |
| 2025-05-22 | Christine Lindenboom | Director | A | +50,000 deriv. | — |
| 2025-05-22 | Tamsin Berry | Director | A | +50,000 deriv. | — |
| 2025-05-22 | Ajay Royan | Director | A | +8,219 deriv. | — |
| 2025-05-22 | Terrance McGuire | Director | A | +50,000 deriv. | — |
| 2025-05-22 | M28 Capital Management LP | — | A | +50,000 deriv. | — |
| 2025-03-26 | Ajay Royan | Director | A | +100,000 deriv. | — |
| 2025-02-19 | Julie Green | Chief Human Resources Officer | A | +1,250,000 deriv. | — |
| 2025-02-19 | Timothy Edward Lee | Chief Commercial Officer | A | +1,250,000 deriv. | — |
| 2025-02-19 | Jill Andersen | Chief Legal Officer, Secretary | A | +1,450,000 deriv. | — |
| 2025-02-19 | Robert D. Allen III | Chief Scientific Officer | A | +1,250,000 deriv. | — |
| 2025-02-19 | William E. Duke | Chief Financial Officer | A | +1,250,000 deriv. | — |
| 2024-12-31 | Terrance McGuire | Director | Sell | −273,763 | −$131.53K |
| 2024-12-26 | Terrance McGuire | Director | Sell | −347,559 | −$164.87K |
| 2024-12-19 | Terrance McGuire | Director | Sell | −324,241 | −$147.80K |
| 2024-12-16 | Terrance McGuire | Director | Sell | −190,359 | −$103.38K |
| 2024-12-11 | Terrance McGuire | Director | Sell | −485,400 | −$289.38K |
| 2024-06-06 | Timothy Edward Lee | Chief Commercial Officer | A | +600,000 deriv. | — |
| 2024-05-31 | Terrance McGuire | Director | Sell | −112,381 | −$186.57K |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Terrance McGuire | Director | 3,170,231 | $1.80M |
| Jill Andersen | Chief Legal Officer, Secretary | 352,236 | $199.94K |
| Timothy Edward Lee | Chief Commercial Officer | 197,362 | $112.03K |
| Robert D. Allen III | Chief Scientific Officer | 195,808 | $111.14K |
| William E. Duke | Chief Financial Officer | 168,937 | $95.89K |
| Julie Green | Chief Human Resources Officer | 168,937 | $95.89K |
| Kevin F McLaughlin | Director | 50,000 | $28.38K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IVVD quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.